Teva Accused Of Asthma Inhaler Antitrust Scheme
Teva was hit with a suit on Monday in Massachusetts federal court that alleges the pharmaceutical giant ran a nearly decadelong anticompetitive scheme to delay generic competition for QVAR, its blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article